« Back to Record
Citation APA

Lei, M., Overman, M. J., Yao, J., André, T., Lonardi, S., Lenz, H.-J., Aglietta, M., Gelsomino, F., McDermott, R., Wong, K. Y. M., Morse, M. M., Van Cutsem, E., Hendlisz, A., Cardin, D. B. D., Neyns, B., Hill, A., Krishnamurthy, A., Chen, F., Kochuparambil, S., Jenq, R. R., Abdullaev, S., He, B., Novosiadly, R., & Kopetz, S. (2025). Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer. Nature communications, 16(1), 8868. doi:10.1038/s41467-025-63960-8


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/402175

Lei, M., Overman, M. J., Yao, J., André, T., Lonardi, S., Lenz, H.-J., Aglietta, M., Gelsomino, F., McDermott, R., Wong, K. Y. M., Morse, M. M., Van Cutsem, E., Hendlisz, A., Cardin, D. B. D., Neyns, B., Hill, A., Krishnamurthy, A., Chen, F., Kochuparambil, S., Jenq, R. R., Abdullaev, S., He, B., Novosiadly, R., & Kopetz, S. (2025). Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer. Nature communications, 16(1), 8868. doi:10.1038/s41467-025-63960-8